RU96104616A - A PEPTIDE HAVING AN INFLUENCE ON THE REGENERATION OF THE BLOOD AND IMMUNE SYSTEMS, AND A PHARMACEUTICAL COMPOSITION BASED ON IT - Google Patents

A PEPTIDE HAVING AN INFLUENCE ON THE REGENERATION OF THE BLOOD AND IMMUNE SYSTEMS, AND A PHARMACEUTICAL COMPOSITION BASED ON IT

Info

Publication number
RU96104616A
RU96104616A RU96104616/14A RU96104616A RU96104616A RU 96104616 A RU96104616 A RU 96104616A RU 96104616/14 A RU96104616/14 A RU 96104616/14A RU 96104616 A RU96104616 A RU 96104616A RU 96104616 A RU96104616 A RU 96104616A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
peptide
regeneration
immune systems
blood
Prior art date
Application number
RU96104616/14A
Other languages
Russian (ru)
Other versions
RU2121480C1 (en
Inventor
В.И. Дейгин
А.М. Коротков
А.М. Поверенный
О.В. Семина
Т.Н. Семенец
Original Assignee
Инженерный центр пептидных препаратов "Пептос"
Filing date
Publication date
Application filed by Инженерный центр пептидных препаратов "Пептос" filed Critical Инженерный центр пептидных препаратов "Пептос"
Priority to RU96104616A priority Critical patent/RU2121480C1/en
Priority claimed from RU96104616A external-priority patent/RU2121480C1/en
Publication of RU96104616A publication Critical patent/RU96104616A/en
Application granted granted Critical
Publication of RU2121480C1 publication Critical patent/RU2121480C1/en

Links

Claims (6)

1. Пептид, обладающий влиянием на регенерацию кроветворной и иммунной систем, формулы
Н-11е-G1u-Тrр-Y,
где Y - ОН или замещенный амид (С1 - С3).
1. The peptide having an effect on the regeneration of the hematopoietic and immune systems, formulas
H-11e-G1u-Trr-Y,
where Y is OH or a substituted amide (C 1 - C 3 ).
2. Фармацевтическая композиция, включающая активный компонент и фармацевтически приемлемый носитель в виде растворителя или наполнителя, отличающийся тем, что в качестве активного компонента содержит пептид по п. 1 в эффективном количестве. 2. A pharmaceutical composition comprising an active ingredient and a pharmaceutically acceptable carrier in the form of a solvent or excipient, characterized in that the active ingredient contains the peptide according to claim 1 in an effective amount. 3. Фармацевтическая композиция по п. 2, отличающийся тем, что находится в форме раствора. 3. The pharmaceutical composition according to claim 2, characterized in that it is in the form of a solution. 4. Фармацевтическая композиция по п.3, отличающаяся тем, что применяется в виде инъекций. 4. The pharmaceutical composition according to claim 3, characterized in that it is used as an injection. 5. Фармацевтическая композиция по п. 3, отличающаяся тем, что предпочтительное содержание указанного пептида составляет от 0,001 до 0,01%. 5. The pharmaceutical composition according to claim 3, characterized in that the preferred content of the indicated peptide is from 0.001 to 0.01%. 6. Фармацевтическая композиция по п. 2, отличающаяся тем, что в твердой форме для орального применения соотношение пептида и наполнителя составляет от 0,01 до 1%. 6. The pharmaceutical composition according to claim 2, characterized in that in solid form for oral administration, the ratio of peptide to excipient is from 0.01 to 1%.
RU96104616A 1996-02-28 1996-02-28 Peptide having effect on regeneration of homogenic and immune systems, and pharmaceutical composition based thereon RU2121480C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96104616A RU2121480C1 (en) 1996-02-28 1996-02-28 Peptide having effect on regeneration of homogenic and immune systems, and pharmaceutical composition based thereon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96104616A RU2121480C1 (en) 1996-02-28 1996-02-28 Peptide having effect on regeneration of homogenic and immune systems, and pharmaceutical composition based thereon

Publications (2)

Publication Number Publication Date
RU96104616A true RU96104616A (en) 1998-05-20
RU2121480C1 RU2121480C1 (en) 1998-11-10

Family

ID=20177851

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96104616A RU2121480C1 (en) 1996-02-28 1996-02-28 Peptide having effect on regeneration of homogenic and immune systems, and pharmaceutical composition based thereon

Country Status (1)

Country Link
RU (1) RU2121480C1 (en)

Similar Documents

Publication Publication Date Title
ES2569949T3 (en) Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine
RU2355700C9 (en) Novel peptides as inhibitors of hepatitis c virus ns3 serine protease
ATE165971T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A DEFINED LIPID SYSTEM
ATE188219T1 (en) PHARMACEUTICAL DIPEPTIDE COMPOSITIONS AND METHODS OF USE.
ATE306906T1 (en) DELAYED RELEASE OF PEPTIDES FROM PHARMACEUTICAL COMPOSITIONS
ATE203415T1 (en) ORAL ADMINISTRATION SYSTEM OF CHEMICALLY MODIFIED PROTEINS G-CSF
RS49566B (en) Compositions comprising antifungal agent and acetate buffer
RU99124179A (en) COMBINATION OF ANALGETICS
KR960000247A (en) Cyclosporine A-containing composition and preparation method thereof
DE69717293D1 (en) PHARMACEUTICAL FORMULATIONS FROM CORTICOTROPIN RELEASING FACTOR WITH IMPROVED STABILITY IN LIQUID FORM
SE8804628D0 (en) NEW COMPOUNDS
RU93004535A (en) COMPOUNDS, METHOD OF OBTAINING AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
PH27446A (en) Compound with gastric acid inhibitory effect
ES2121940T3 (en) ANTITUMORAL COMPOSITIONS AND TREATMENT PROCEDURES.
RU99107658A (en) APPLICATION OF PROTEINS AS AN AGENT AGAINST AUTOIMMUNE DISEASES
IT1204400B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
RU96104616A (en) A PEPTIDE HAVING AN INFLUENCE ON THE REGENERATION OF THE BLOOD AND IMMUNE SYSTEMS, AND A PHARMACEUTICAL COMPOSITION BASED ON IT
RU92004569A (en) PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION
RU95121837A (en) PHARMACEUTICAL COMPOSITION HAVING AN IMMUNOMODELING AND HYPOLIPIDEMIC ACTION
EA199700302A1 (en) BIOLOGICALLY ACTIVE UREID-DERIVATIVES, USEFUL AT TREATMENT OF MULTIPLE SCLEROSIS
DE69902925D1 (en) New injectable medicinal preparations containing ramoplan
ATE64307T1 (en) INJECTABLE MEDICINAL FORMULATIONS OF SUBSTANCES WITH GENERAL ANESTHETIC EFFECTS.
EP0367509A3 (en) Formulations
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical
ITRM910038A1 (en) PHARMACEUTICAL COMPOSITIONS HAVING CALCITONIN AS AN ACTIVE SUBSTANCE TO BE ADMINISTERED INTRANASALLY.